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t is well established that diabetes 
mellitus is associated with adverse 
health outcomes. Data from 
general population cohorts indicate a 
2- to 3-fold increase in cardiovascular 
risks and about a 50 percent increase 
in the risks of non-cardiovascular 
mortality associated with this condition 
[1–3]. These associations appear 
largely consistent across populations in 
different regions of the world [3]. 
    There is some evidence that 
diabetes may be a more important 
determinant of cardiovascular risk for 
women than men [4]. However, the 
relative effects of diabetes on vascular 
and other diseases among older, 
compared with younger, individuals 
is less certain. Heterogeneity by age 
in the association between diabetes 
and cardiovascular disease has been 
reported, with a consistently weaker 
association observed among older 
individuals [3,5]. Given this possible 
age-dependency in the epidemiological 
associations, and the frequent 
observation that cardiovascular 
risk factors are often managed less 
aggressively in older people than 
in younger people [6], a better 
understanding of the relationship 
between diabetes and disease-speciﬁ  c 
causes of death among older people is 
important.
    A New Cohort Study
    In this regard, the data provided 
by Kronmal and colleagues in   PLoS 
Medicine   [7] make an important 
contribution to our knowledge of 
morbidity and mortality associated 
with diabetes mellitus in older adults. 
The researchers evaluated a randomly 
selected cohort of 5,372 people aged 
65 years and over, of whom 8.8 percent 
were known to have a diagnosis of 
diabetes and were treated with oral 
hypoglycaemic agents and/or insulin 
at baseline. After an average of 11.1 
years follow-up, over 40 percent of the 
cohort had died, with approximately 
50 to 60 percent of these deaths 
attributed to cardiovascular causes. 
Compared to those without diabetes, 
and after adjustment for a wide range 
of covariates, individuals with known, 
treated diabetes had an estimated 
excess risk of death ranging between 
approximately 30 and 100 percent, 
depending on whether or not they were 
treated with insulin. For cardiovascular 
mortality, there was a 2-fold increased 
risk associated with diabetes. 
    However, it is likely that the 
reported hazard ratios in this study 
underestimate the true strength of 
associations between diabetes and 
cause-speciﬁ  c mortality, for two 
important reasons. First, participants 
without a diagnosis of diabetes, but 
with a fasting blood glucose level 
consistent with this diagnosis, were 
considered not to have diabetes. 
Second, for cardiovascular mortality, 
inclusion of subclinical atherosclerosis 
as a covariate probably represents over-
adjustment. 
    Nonetheless, these data provide 
reliable evidence that diabetes is 
an important adverse risk factor 
among older adults, with estimates 
of the strength of the associations 
comparable to published data from 
younger cohorts. Furthermore, in 
this population of (albeit limited) age 
range, no age interactions in any of 
these associations were observed.
    Kronmal and colleagues also report 
on analyses suggesting that the relative 
risks of non-cardiovascular disease 
mortality associated with diabetes, 
particularly with respect to death due 
to infectious or renal causes, were 
signiﬁ  cantly greater among individuals 
treated with insulin compared with 
those receiving oral hypoglycaemic 
agents alone. They further report 
that women with diabetes on insulin 
had a particularly high risk of death 
compared with women without 
diabetes. These ﬁ  ndings are interesting 
but, in relation to any implication 
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that insulin use may lead to poorer 
outcomes, can only be considered 
hypothesis-generating. 
    One of the strengths of this new 
study is the availability of data relating 
to a large number of potentially 
confounding variables at baseline, and 
adjustment for these factors has been 
appropriately made. However, as is 
always the case with observational data, 
one cannot account for unmeasured 
(e.g. duration of diabetes [8]) or 
unknown risk factors, and residual 
confounding remains a highly plausible 
explanation for these ﬁ  ndings. 
  Clinical  Implications
    So what are the implications of 
the results of this study for clinical 
practice? Primarily, these data conﬁ  rm 
that older adults with diabetes are at 
very high   absolute   risk of death from 
cardiovascular causes (four to ﬁ  ve 
percent per year). Thus, strategies 
aimed at reducing these risks should 
be aggressively pursued among such 
individuals, wherever possible. 
    Fortunately, a range of preventive 
treatments of proven efﬁ  cacy are at 
our disposal, including blood pressure 
lowering [9] and the use of statins 
[10]. Intensive glucose lowering in 
type 2 diabetes has been shown to 
reduce microvascular (retinal and 
renal) events. However, the balance 
of risks and beneﬁ  ts of lowering 
haemoglobin A1c levels below seven 
percent (as recommended by many 
current guidelines), particularly 
with respect to macrovascular events 
such as myocardial infarction and 
stroke, remains uncertain. At least 
two large-scale randomised clinical 
trials evaluating this question are 
ongoing, one of which has no upper 
age restriction [11] while the other 
includes participants aged up to 
80 years at randomisation [12]. 
Importantly, to reach such targets for 
intensive glucose lowering, insulin 
therapy will be frequently required. 
Should the trials demonstrate that the 
beneﬁ  ts of intensive glucose lowering 
outweigh the risks, these data, rather 
than observational data suggesting 
possible harm associated with the use 
of insulin, should take precedence in 
guiding clinical practice.   
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